Tailor your communication towards your patients with a cardiovascular risk calculator

According to the recent 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, the importance of atherosclerosis cardiovascular (CV) disease prevention remains undisputed and should be delivered:

  • at the general population level by promoting healthy lifestyle behavior
  • at the individual level by tackling unhealthy lifestyles and by reducing levels of causal CV risk factors, such as low-density lipoprotein cholesterol (LDL-c), non-high density lipoprotein cholesterol (non-HDLc) and/or blood pressure.1

Healthcare professionals need to tailor their communication to individual patients.

Evaluating the cardiovascular risk on an individual basis can not only help support clinical decision-making in managing patients, for instance by helping patients to set individual goals.

HCPs can help support this behavior change by showing their patients the consequences of poor-lipid control, which is a direct consequence of non-medication adherence, or unhealthy lifestyle habits.2

This innovative cardiovascular risk calculator is an easy-to-use tool, based on the 2021 ESC guidelines, which can be used with any patient, including those in a very high-risk category.

It uses Non-HDLc as an input in the Systemic Coronary Risk Estimation 2 (SCORE23) and SCORE2-Older Persons (SCORE2-OP4) risk algorithms.

It also provides healthcare professionals with recommendations for both LDL-c and non-HDLc targets, in line with ESC/EAS guidelines.1


  1. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337.
  2. Michie S, Wood CE, Johnston M, Abraham C, Francis JJ, Hardeman W. Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data). Health Technol Assess. 2015 Nov;19(99):1-188.
  3. SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021 Jul 1;42(25):2439-2454.
  4. SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021 Jul 1;42(25):2455-2467.

Endorsed by